Table of Content

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing R&D Activities in the Life Sciences Industry
4.2.2. Growing Automation in Laboratories
4.2.3. Technological Advancements in Laboratory Informatics Solutions
4.2.4. Stringent Regulatory Requirements
4.3. Restraints
4.3.1. Cost Constraints
4.4. Opportunities
4.4.1. Emerging Economies
4.4.2. Cloud-based LIMS
4.5. Challenges
4.5.1. Lack of Integration Standards for LIMS
4.5.2. Migrating from Legacy LIMS to New Systems
4.5.3. Data Security and Privacy Concerns
4.5.4. Shortage of Skilled Professionals
4.6. Standards and Compliance Analysis
4.7. Pricing Analysis

5. Global LIMS Market, by Mode of Delivery
5.1. Introduction
5.2. Web and Cloud-based LIMS
5.3. On-Premise LIMS

6. Global LIMS Market, by Offering
6.1. Introduction
6.2. Software
6.3. Services

7. Global LIMS Market, by Type
7.1. Introduction
7.2. Multi-purpose LIMS
7.3. Purpose-built LIMS

8. Global LIMS Market, by End User
8.1. Introduction
8.2. Life Sciences
8.2.1. Pharmaceutical & Biotechnology Companies
8.2.2. Academic & Research Institutes
8.2.3. Biobanks & Biorepositories
8.2.4. Contract Research Organizations (CRO)
8.2.5. Others
8.3. Food & Beverage Industry
8.4. Petrochemicals and Oil & Gas Industries
8.5. Chemical Industry
8.6. Environmental Testing Laboratories
8.7. Others

9. LIMS Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America (RoLATAM)
9.6. Middle East & Africa

10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Dashboard
10.3.1. Industry Leaders
10.3.2. Market Differentiators
10.3.3. Vanguards
10.3.4. Emerging Companies
10.4. Vendor Market Positioning
10.5. Market Share Analysis (2022)
10.5.1. Overall Market Share Analysis
10.5.1.1. LabWare, Inc.
10.5.1.2. Thermo Fisher Scientific Inc.
10.5.1.3. Dassault Syst?mes
10.5.1.4. LabVantage Solutions Inc.
10.5.1.5. STARLIMS Corporation

11. Company Profiles (Business Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)
11.1. LabWare, Inc.
11.2. Thermo Fisher Scientific Inc.
11.3. LabVantage Solutions Inc.
11.4. LabLynx, Inc.
11.5. Labworks LLC
11.6. Agilent Technologies, Inc.
11.7. Labii Inc.
11.8. Accelerated Technology Laboratories, Inc.
11.9. LABTrack
11.10. Computing Solutions, Inc.
11.11. Dassault Syst?mes
11.12. Ovation
11.13. CLOUDLIMS.com
11.14. STARLIMS Corporation (A Subsidiary of Francisco Partners)
11.15. Autoscribe Informatics
11.16. Illumina, Inc.
11.17. Siemens AG
11.18. Novatek International

12. Appendix
12.1. Available Customization
12.2. Related Reports



List of Figures

List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global LIMS Market Size, by Mode of Delivery, 2023 Vs. 2030 (USD Million)
Figure 8 Global LIMS Market Size, by Offering, 2023 Vs. 2030 (USD Million)
Figure 9 Global LIMS Market Size, by Type, 2023 Vs. 2030 (USD Million)
Figure 10 Global LIMS Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 11 Global LIMS Market, by Geography
Figure 12 Market Dynamics
Figure 13 Number of New Chemical and Biological Entities Approved (2002–2021)
Figure 14 Global Pharmaceutical R&D Expenditure, 2014–2026 (USD Billion)
Figure 15 Global LIMS Market Size, by Mode of Delivery, 2023 Vs. 2030 (USD Million)
Figure 16 Global LIMS Market Size, by Offering, 2023 Vs. 2030 (USD Million)
Figure 17 Global LIMS Market Size, by Type, 2023 Vs. 2030 (USD Million)
Figure 18 Global LIMS Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 19 Number of Biologics Approved by the USFDA between 2015 And 2022
Figure 20 Global Pharmaceutical R&D Spending, 2022–2028 (USD Billion)
Figure 21 Global Drug R&D Pipeline Size (2015–2022)
Figure 22 Global Pharmaceutical R&D Expenditure (2016–2028)
Figure 23 Global LIMS Market Size, by Geography, 2023–2030 (USD Million)
Figure 24 North America: LIMS Market Snapshot
Figure 25 U.S.: GROSS DOMESTIC SPENDING ON R&D (2016–2020)
Figure 26 Pharmaceutical R&D Expenditure in the U.S., 1990–2020
Figure 27 Canada: Research and Development Expenditure (Percentage of GDP)
Figure 28 Pharmaceutical Industry R&D Expenditure in Europe (1990–2021)
Figure 29 Europe: LIMS Market Snapshot
Figure 30 Germany: Gross Domestic Spending on R&D (2014–2020)
Figure 31 U.K.: Gross Domestic Spending on R&D (2016–2019)
Figure 32 France: Indirect R&D Tax Incentives (USD Million)
Figure 33 France: Gross Domestic Spending On R&D (2016-2020)
Figure 34 Gross Domestic Spending on R&D (% of GDP, 2016–2020)
Figure 35 Gross Domestic Spending on R&D (% of GDP, 2016–2020)
Figure 36 Pharmaceutical R&D Spending in the Rest of Europe (2020)
Figure 37 Asia-Pacific: LIMS Market Snapshot
Figure 38 Japan: R&D Expenditure as a Percentage of GDP (2015–2020)
Figure 39 Pharmaceutical Industry R&D Expenditure (2000 Vs 2010 Vs 2019 Vs 2020)
Figure 40 Pharmaceutical Industry R&D Expenditure (2001 Vs 2010 Vs 2019 Vs 2020)
Figure 41 Latin America: LIMS Market Snapshot
Figure 42 Key Growth Strategies Adopted by Leading Players (2019–2023)
Figure 43 Competitive Dashboard: LIMS Market
Figure 44 Global LIMS Market: Competitive Benchmarking, By Type
Figure 45 Overall Market Share Analysis: LIMS Market (2022)
Figure 46 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 47 Agilent Technologies, Inc.: Financial Overview (2022)
Figure 48 Dassault Syst?mes: Financial Overview (2021)
Figure 49 Illumina, Inc.: Financial Overview (2021)
Figure 50 Siemens AG: Financial Overview (2022)